| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1030959280 |
| P356 | DOI | 10.1054/BJOC.2000.1646 |
| P932 | PMC publication ID | 2363804 |
| P698 | PubMed publication ID | 11237391 |
| P5875 | ResearchGate publication ID | 12095299 |
| P2093 | author name string | A E Lykkesfeldt | |
| S S Larsen | |||
| I Heiberg | |||
| P2860 | cites work | A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer | Q28368253 |
| Seocalcitol (EB 1089): a vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluation | Q33927758 | ||
| 17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. | Q33962903 | ||
| EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro | Q35028096 | ||
| Indirect mechanism of oestradiol stimulation of cell proliferation of human breast cancer cell lines | Q36027345 | ||
| Differential regulation of specific genes in MCF-7 and the ICI 182780-resistant cell line MCF-7/182R-6. | Q36618242 | ||
| Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells | Q38318911 | ||
| A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780. | Q38351774 | ||
| Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens | Q40470534 | ||
| 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells | Q40859289 | ||
| Reversal of hypercalcemia with the vitamin D analogue EB1089 in a human model of squamous cancer. | Q40940280 | ||
| Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness | Q41083185 | ||
| Antiproliferative action of vitamin D-related compounds and insulin-like growth factor-binding protein 5 accumulation | Q41110785 | ||
| Estrogen receptor messenger RNA splice variants are not involved in antiestrogen resistance in sublines of MCF-7 human breast cancer cells | Q41127543 | ||
| Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells. | Q41191360 | ||
| Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment | Q41345051 | ||
| Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1. | Q41480629 | ||
| Effect of estrogen and antiestrogens on cell proliferation and synthesis of secreted proteins in the human breast cancer cell line MCF-7 and a tamoxifen resistant variant subline, AL-1. | Q41645493 | ||
| Differential effects of 1,25-dihydroxyvitamin D3 and tetradecanoylphorbol acetate on cell cycle and apoptosis of MCF-7 cells and a vitamin D3-resistant variant | Q42546942 | ||
| MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen | Q42815735 | ||
| Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells. | Q52525004 | ||
| Dissociation of vitamin D3 and anti-estrogen mediated growth regulation in MCF-7 breast cancer cells. | Q52532663 | ||
| Acquired antiestrogen resistance in MCF-7 human breast cancer sublines is not accomplished by altered expression of receptors in the ErbB-family. | Q54065729 | ||
| Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer. | Q54172521 | ||
| Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells. | Q54254361 | ||
| Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53 | Q59487853 | ||
| Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy | Q62690767 | ||
| p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients | Q71059816 | ||
| The value of estrogen and progesterone receptors in the treatment of breast cancer | Q71432010 | ||
| Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis | Q71512317 | ||
| Checkpoints of dueling dimers foil death wishes | Q72790765 | ||
| Clinical significance of bcl-2 gene expression in human breast cancer tissues | Q73313971 | ||
| bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study | Q73368662 | ||
| Vitamin D analogues suppress IGF-I signalling and promote apoptosis in breast cancer cells | Q73446751 | ||
| The expression of Ki-S1 and BCL-2 and the response to primary tamoxifen therapy in elderly patients with breast cancer | Q73533098 | ||
| Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases | Q73603139 | ||
| Vitamin D compounds as potential therapeutics for estrogen-independent breast cancer | Q73844927 | ||
| Vitamin D derivatives inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cells | Q73900538 | ||
| Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3 | Q74346662 | ||
| EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells | Q77609554 | ||
| Apoptosis and Bcl-2 expression in relation to age, tumor characteristics and prognosis in breast cancer. South-East Sweden Breast Cancer Group | Q77982200 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vitamin D | Q175621 |
| P304 | page(s) | 686-90 | |
| P577 | publication date | 2001-03-02 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Anti-oestrogen resistant human breast cancer cell lines are more sensitive towards treatment with the vitamin D analogue EB1089 than parent MCF-7 cells | |
| P478 | volume | 84 |
| Q38943401 | A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells. |
| Q40663105 | Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice |
| Q36452355 | Jostling for position: optimizing linker location in the design of estrogen receptor-targeting PROTACs |
| Q37097049 | Prognostic value of Bcl-2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy |
| Q40522824 | Sequential versus combined treatment of human breast cancer cells with antiestrogens and the vitamin D analogue EB1089 and evaluation of predictive markers for vitamin D treatment |
Search more.